Alliance Richard J. Read  

ACT Against COVID: The Alliance for Comprehensive Testing (ACT) launches a digital tool “Testing at the right time” | New

SECAUCUS, New Jersey, September 8, 2021 / PRNewswire / – Today, ACT Against COVID: The Alliance for Comprehensive Testing (ACT), a diverse alliance of organizations dedicated to providing people with information about widespread COVID-19 testing, released a new digital tool to help individuals determine which type of COVID-19 test makes the most sense for them. The tool will help them understand whether a molecular (i.e. PCR), antigen or antibody test should be used based on their symptoms, exposure, and access to tests. The Right Test Right Time tool can also help organizations identify the right testing protocols for their community.

With the increase in COVID-19 cases in parts of the country, fueled largely by the highly transmissible Delta variant, there is an increasing urgency for widespread testing to slow the spread. But even after more than a year of the pandemic, there remains a lack of understanding of how and when the various COVID-19 tests should be used.

“COVID-19 testing remains one of our best defenses against the virus, especially for those who are unvaccinated or otherwise vulnerable to the disease. However, there are several types of COVID-19 tests available and knowing which test may be appropriate can be confusing, “mentioned Hema Kapoor, MD, Senior Medical Director, Infectious Diseases / Immunology and Global Diagnostics Quest Diagnostics. “The ACT Alliance launched this digital tool to help people better understand whether an antigen, antibody or molecular test is right for them.”

There are three types of COVID-19 tests, each playing a different role in a comprehensive testing program:

  • PCR tests are used to accurately detect active infections. It is a type of molecular test and considered the gold standard for testing. PCR is the most commonly used nucleic acid amplification test (NAAT).
  • The antigen test is used to identify active infections. It expands testing capability as a fast, reliable and affordable screening and diagnostic option.
  • Antibody tests determine if a person has ever been infected with COVID-19.

ACT is committed to helping the public and community leaders understand which COVID-19 test is best suited for their situation. The right testing tool at the right time helps guide individuals to the test that is best for them. This simple, interactive tool allows the user to choose from a variety of situations, such as having symptoms of COVID-19 or being in close contact with someone with COVID-19, to determine the appropriate test to take. This information can help people make more informed decisions about their testing needs.

“Our hope is that this tool will encourage people to get the right test they need, when they need it. Testing for COVID-19 infections as early as possible will help avoid exposure to others and prevent further spread, ”commented Dr. Kapoor.

The right testing tool at the right time can be found here:

For more information on ACT Against COVID, visit

About ACT Against COVID: The Alliance for Comprehensive Testing (ACT)

ACT Against COVID: The Alliance for Comprehensive Testing (ACT) is a diverse alliance that began as an effort to clarify the value of COVID-19 molecular, antigen and antibody testing and how to access it. It brings together a wide range of organizations, health and public health professionals, officials and others who share the belief that comprehensive testing solutions are an essential tool to help slow and possibly stop the spread. of COVID-19. The Alliance is advocating for testing to be a powerful tool to tackle new variants as they emerge, to better understand how the virus spreads in communities and to uncover hidden pandemics. Implementing comprehensive testing strategies will support ongoing wellness and help us resume responsible living.

View original content to download multimedia: -time-tool-301371417.html

SOURCE ACT Against COVID: The Alliance for Comprehensive Testing

Source link